Article
US FDA approves Emergent BioSolutions' anthrax vaccine
Rating:
0.0
Views:
37
Likes:
1
Library:
1
Emergent BioSolutions said on Thursday the U.S. Food and Drug Administration has approved its anthrax vaccine for use in adults aged 18 through 65.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value